Pharmaceutical

AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq

AbbVie is seeking regulatory approval in the US and EU for Rinvoq as a treatment for giant cell arteritis.

Jul 16, 2024 - 04:00
AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq
AbbVie is seeking regulatory approval in the US and EU for Rinvoq as a treatment for giant cell arteritis.
Read the original article

Tags:

Previous Article

Delix plans further trials with neuroplastogen after positive Phase I data

Next Article

Conflict means millions of children are missing vaccinations, UN says

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Over 20,000 UK businesses at risk of Chinese espionage, warns MI5 chief

Over 20,000 UK businesses at risk of Chinese espionage,...

Oct 21, 2023

STAT+: What the Dana-Farber, Brigham divorce means for patients

STAT+: What the Dana-Farber, Brigham divorce means for ...

Sep 22, 2023

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024